MedTrace Logo

Effects of Cocoa Products on Cardiovascular Disease Risk Factors

NCT00511420 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 113

Last updated 2007-08-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of optimized composition chocolates that include natural ingredients with demonstrated biological activity are observed cardioprotectores effects in the human.

Conditions

Interventions

DIETARY_SUPPLEMENT

Cocoa product type 1

6 doses of 13 grams per day during 4 weeks with a prior stabilization period of 2 weeks.

DIETARY_SUPPLEMENT

Cocoa product type 2

6 doses of 13 grams per day during 4 weeks with a prior stabilization period of 2 weeks with cocoa product type 1

DIETARY_SUPPLEMENT

Cocoa product type 3

6 doses of 13 grams per day during 4 weeks with a prior stabilization period of 2 weeks with cocoa product type 1

DIETARY_SUPPLEMENT

Cocoa product type 4

6 doses of 13 grams per day during 4 weeks with a prior stabilization period of 2 weeks with cocoa product type 1

Sponsors & Collaborators

  • University Rovira i Virgili

    lead OTHER

Principal Investigators

  • Rosa Sola, Dra/Prof · University Rovira i Virgili

  • Bartolome Ramirez, Mr · La Morella Nuts, S.A.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-04-30
Completion
2005-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00511420 on ClinicalTrials.gov